C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma

[1]  J. Boone,et al.  Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease , 2020, European journal of gastroenterology & hepatology.

[2]  Yingxing Wu,et al.  Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease , 2020, Digestive Diseases and Sciences.

[3]  Siddharth Singh,et al.  AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. , 2020, Gastroenterology.

[4]  J. Weinberg,et al.  Role of Cycle Threshold in Clostridioides difficile Polymerase Chain Reaction Testing as a Predictor of Clinical Outcomes in Patients With Inflammatory Bowel Disease , 2019, Crohn's & Colitis 360.

[5]  Laura L Durbin,et al.  Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile. , 2018, Inflammatory bowel diseases.

[6]  M. Wilcox,et al.  The predictive value of quantitative nucleic acid amplification detection of Clostridium difficile toxin gene for faecal sample toxin status and patient outcome , 2018, bioRxiv.

[7]  K. Carroll,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  E. Robilotti,et al.  Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer. , 2017, The Journal of infection.

[9]  M. Mulligan,et al.  Innate, T-, and B-Cell Responses in Acute Human Zika Patients , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Shin,et al.  Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  P. Pothier,et al.  Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in France. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  M. Hellmich,et al.  PCR cycle threshold value predicts the course of Clostridium difficile infection. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.